Guardant Health, Inc.

Insider Sentiment (TTM):

Last Purchase:2026-06-15Last Sale:2026-06-29Shares Purchased (TTM):600Shares Sold (TTM):1,382,357

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:124,591,853Shares Outstanding:131,273,000Institutional Ownership Pct.:94.91%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Medical Laboratories

NTRA DGX LH CELC CAI RDNT

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	989	378	580	629	699	526	688	1,035	1,129	1,134	457	271
Available For Sale Securities Debt Securities Curr…	113	823	0	0	0	314	311	0	0	35	697	954
Accounts Receivable Net Current	137	138	116	130	115	110	88	101	85	89	89	86
Inventory Net	84	86	90	84	77	71	72	67	63	62	77	61
Prepaid Expense And Other Assets Current	43	41	43	40	36	34	67	87	32	28	26	26
Assets Current	1,368	1,466	829	883	927	1,055	1,227	1,290	1,309	1,347	1,347	1,398
Restricted Cash Noncurrent	112	111	110	106	105	104	103	102	100	0	-	-
Property Plant And Equipment Net	150	146	125	126	129	137	125	132	138	145	148	156
Operating Lease Right Of Use Asset	154	159	164	170	141	142	145	146	152	158	162	165
Intangible Assets Net Excluding Goodwill	26	26	5	6	6	7	7	8	8	9	10	10
Goodwill	77	77	3	3	3	3	3	3	3	3	3	3
Other Assets Noncurrent	29	28	41	37	33	37	31	30	94	124	128	108
Assets	1,915	2,014	1,277	1,332	1,344	1,486	1,539	1,609	1,705	1,786	1,797	1,840
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	188	205	189
Accounts Payable Current	75	54	20	45	50	39	15	42	38	52	-	-
Accrued Employee Benefits Current	91	120	98	68	64	83	81	59	93	73	-	-
Other Accrued Liabilities Current	-	78	-	-	-	68	-	-	-	63	-	-
Accrued Liabilities Current	78	78	72	71	76	68	72	71	67	-	-	-
Contract With Customer Liability Current	48	51	47	54	36	35	30	29	23	18	21	12
Liabilities Current	292	303	237	238	226	226	197	202	220	206	227	201
Convertible Debt Noncurrent	1,503	1,504	1,115	1,116	1,116	1,143	1,142	1,141	1,141	1,140	1,139	1,139
Operating Lease Liability Noncurrent	173	178	185	192	160	164	170	172	179	186	193	198
Other Liabilities Noncurrent	128	128	94	91	93	93	89	96	97	96	10	9
Liabilities	2,096	2,113	1,631	1,637	1,595	1,625	1,599	1,611	1,636	1,628	1,569	1,547
Stockholders Equity
Preferred Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-	-	-45	-45	45	-	-	-	-	-	-	-
Additional Paid In Capital	2,931	2,900	2,561	2,517	2,472	2,444	2,410	2,364	2,330	2,304	2,189	2,170
Accumulated Other Comprehensive Income Loss Net Of…	-5	-5	-4	-4	-5	-5	-3	-6	-5	-4	-6	-8
Retained Earnings Accumulated Deficit	-3,107	-2,995	-2,866	-2,773	-2,673	-2,578	-2,467	-2,359	-2,257	-2,142	-1,955	-1,869
Stockholders Equity	-181	-99	-354	-305	-251	-140	-60	-2	68	159	228	293
Liabilities And Stockholders Equity	1,915	2,014	1,277	1,332	1,344	1,486	1,539	1,609	1,705	1,786	1,797	1,840
Debt Instrument Face Amount	-	-	1,091	1,091	1,091	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	80	80	80	80	80	80	80	80	80	80	80	80
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	350	350	350	350	350	350	350	350	350	350	350	350
Common Stock Shares Issued	132	131	126	125	125	124	123	123	122	122	118	118
Shares Outstanding	132	131	125	124	124	124	123	123	122	122	118	118
Treasury Stock Common Shares	-	-	1	1	1	-	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	40.57%	61.74%	59.69%	-	-	-	-	-	-	-	-	-
2025	-19.54%	4.04%	-1.63%	35.87%	30.89%	44.86%	45.87%	38.01%	55.17%	-19.64%	-26.11%	-10.04%
2024	39.40%	48.56%	69.75%	-24.68%	-32.63%	-39.61%	40.81%	20.36%	86.67%	-9.51%	-7.78%	-11.98%
2023	35.01%	49.23%	61.82%	7.74%	-27.04%	-27.88%	-5.08%	-2.49%	-16.73%	-20.34%	-18.01%	0.45%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.68	4.84	3.50	3.71	4.11	4.68	6.22	6.40	5.95	6.54	5.94	6.96
Quick Ratio	4.25	4.42	2.94	3.18	3.61	4.21	5.51	5.63	5.52	6.11	5.48	6.53
Working Capital	1.08B	1.16B	591.97M	645.00M	701.27M	829.53M	1.03B	1.09B	1.09B	1.14B	1.12B	1.20B
Leverage & Debt
Debt to Equity	-11.58	-21.28	-4.60	-5.36	-6.36	-11.64	-26.60	-998.73	23.96	10.26	6.87	5.29
Interest Coverage TTM	-100.51	-112.20	-131.59	-150.33	-166.83	-171.87	-199.59	-198.28	-205.64	-219.06	-199.20	-211.25
Debt Ratio	1.09	1.05	1.28	1.23	1.19	1.09	1.04	1.00	0.96	0.91	0.87	0.84
Efficiency & Turnover
Asset Turnover TTM	0.66	0.56	0.64	0.56	0.51	0.45	0.42	0.37	0.38	0.33	0.31	0.28
Days Sales Outstanding TTM	42.72	46.11	41.26	50.81	47.16	49.15	46.73	53.00	51.92	60.20	59.61	65.02
Receivables Turnover TTM	8.54	7.92	8.85	7.18	7.74	7.43	7.81	6.89	7.03	6.06	6.12	5.61
Per Share Metrics
Diluted EPS TTM	-3.30	-3.32	-3.20	-3.33	-3.36	-3.56	-4.16	-4.01	-3.79	-4.28	-3.67	-4.67
Free Cash Flow Per Share TTM	-1.81	-1.86	-2.10	-2.19	-2.46	-2.24	-2.23	-2.44	-2.47	-3.08	-3.09	-3.52
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	64.90%	64.46%	63.76%	62.84%	61.34%	60.79%	69.44%	78.81%	89.50%	100.46%	100.48%	100.51%
Operating Profit Margin TTM	-41.43%	-44.53%	-49.02%	-55.59%	-58.78%	-60.02%	-74.41%	-79.43%	-87.85%	-100.14%	-95.81%	-106.71%
Net Profit Margin TTM	-40.10%	-42.39%	-44.18%	-49.93%	-53.82%	-59.05%	-74.02%	-76.23%	-76.34%	-85.02%	-80.69%	-99.62%
Growth Metrics
Net Revenue Growth (1Y)	39.56%	32.88%	30.38%	28.74%	28.20%	31.04%	29.20%	26.20%	25.21%	25.45%	24.38%	25.00%
Net Income Growth (1Y)	4.00%	-4.61%	-22.17%	-15.68%	-9.62%	-8.98%	18.52%	-3.44%	-30.68%	-26.76%	-28.61%	-7.78%
EPS Growth (1Y)	-1.87%	-6.61%	-23.27%	-16.81%	-11.20%	-16.96%	13.40%	-14.19%	-41.53%	-33.17%	-37.97%	-13.51%
Valuation Metrics
P/E TTM	-27.99	-30.76	-19.55	-15.61	-12.67	-8.59	-5.51	-7.21	-5.45	-6.32	-8.07	-7.66
P/B TTM	-66.97	-128.95	-22.00	-21.14	-21.04	-26.85	-46.97	-2,192.36	36.77	19.09	15.29	13.31
P/S TTM	11.23	13.04	8.64	7.79	6.82	5.07	4.08	5.49	4.16	5.37	6.51	7.64
Market Cap	12.13B	12.81B	7.80B	6.46B	5.28B	3.75B	2.82B	3.54B	2.51B	3.03B	3.49B	3.90B
Enterprise Value	12.53B	13.93B	8.22B	6.84B	5.59B	4.26B	3.28B	3.64B	2.62B	3.99B	4.17B	4.76B
Calculated Values
Free Cash Flow TTM	-237.12M	-233.07M	-262.23M	-271.73M	-304.87M	-274.94M	-274.36M	-299.27M	-300.71M	-345.46M	-363.41M	-383.13M
Net Debt	402.03M	1.13B	425.08M	380.05M	312.49M	512.79M	453.53M	106.02M	111.58M	958.51M	681.98M	867.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Talasaz, Amirali

Title: Co-Chief Executive Officer

Shares: 143,028

Price/Share: $151.80

Value: $21,711,650.40

Shares Owned: 1,881,336

Relationship: Director,Officer

Ownership: Indirect

2026-06-22Sale

Owner: Potter, Myrtle S

Title: -

Shares: 1,556

Price/Share: $131.16

Value: $204,084.96

Shares Owned: 20,971

Relationship: Director

Ownership: Direct

2026-06-22Sale

Owner: Tariq, Musa

Title: -

Shares: 1,951

Price/Share: $131.16

Value: $255,893.16

Shares Owned: 11,048

Relationship: Director

Ownership: Direct

2026-06-16Sale

Owner: Tariq, Musa

Title: -

Shares: 116

Price/Share: $130.19

Value: $15,102.04

Shares Owned: 8,796

Relationship: Director

Ownership: Direct

2026-06-15Purchase

Owner: Kalia, Kumud

Title: Chief Information Officer

Shares: 600

Price/Share: $130.76

Value: $78,456.00

Shares Owned: 41,414

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Indirect	Sale	143,028	151.80	$21,711,650.40	1,881,336	4
2026-06-22	Potter, Myrtle S	Director	-	Direct	Sale	1,556	131.16	$204,084.96	20,971	4
2026-06-22	Tariq, Musa	Director	-	Direct	Sale	1,951	131.16	$255,893.16	11,048	4
2026-06-16	Tariq, Musa	Director	-	Direct	Sale	116	130.19	$15,102.04	8,796	4
2026-06-15	Kalia, Kumud	Officer	Chief Information Officer	Direct	Purchase	600	130.76	$78,456.00	41,414	4
2026-06-15	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	600	131.08	$78,648.00	40,814	4
2026-06-11	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	3,418	130.24	$445,160.32	41,090	4
2026-06-05	Bell, Michael Brian	Officer	Chief Financial Officer	Direct	Sale	2,000	128.62	$257,240.00	47,509	4
2026-06-05	Eltoukhy, Helmy	Director,Officer	Co-Chief Executive Officer	Indirect	Sale	100,000	128.82	$12,882,000.00	2,012,919	4
2026-06-04	Krognes, Steve E.	Director	-	Direct	Sale	9,294	132.51	$1,231,547.94	10,222	4
2026-06-03	Joyce, Meghan V.	Director	-	Direct	Sale	10,000	127.74	$1,277,400.00	11,183	4
2026-05-28	Hidalgo, Medina Manuel	Director	-	Direct	Sale	1,000	130.06	$130,060.00	639	4
2026-05-27	Saia, John G.	Officer	Chief Legal Officer	Direct	Sale	10,000	125.58	$1,255,800.00	35,950	4
2026-05-22	Freeman, Chris	Officer	Chief Commercial Officer	Direct	Sale	24,406	118.67	$2,896,260.02	60,034	4
2026-05-20	Clark, Ian T	Director	-	Indirect	Sale	6,876	106.90	$735,044.40	2,975	4
2026-05-20	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Indirect	Sale	210,000	107.36	$22,545,600.00	1,886,504	4
2026-05-20	Hidalgo, Medina Manuel	Director	-	Direct	Sale	1,250	107.08	$133,850.00	1,639	4
2026-05-20	Saia, John G.	Officer	Chief Legal Officer	Direct	Sale	20,000	106.43	$2,128,600.00	45,950	4
2026-05-18	Tariq, Musa	Director	-	Direct	Sale	116	95.96	$11,131.36	8,662	4
2026-05-12	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Indirect	Sale	50,000	100.32	$5,016,000.00	2,096,504	4
2026-04-16	Tariq, Musa	Director	-	Direct	Sale	116	84.83	$9,840.28	8,528	4
2026-04-06	Monroe, Terilyn J.	Officer	Chief People Officer	Direct	Sale	3,832	92.68	$355,149.76	20,990	4
2026-03-18	Tariq, Musa	Director	-	Direct	Sale	348	88.09	$30,655.32	8,394	4
2026-03-16	Bell, Michael Brian	Officer	Chief Financial Officer	Direct	Sale	3,000	87.04	$261,120.00	43,601	4
2026-03-06	Hidalgo, Medina Manuel	Director	-	Direct	Sale	1,300	91.46	$118,898.00	1,193	4
2026-03-04	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	40,000	95.43	$3,817,200.00	37,643	4
2026-01-21	Monroe, Terilyn J.	Officer	Chief People Officer	Direct	Sale	8,571	113.84	$975,722.64	20,990	4
2026-01-07	Monroe, Terilyn J.	Officer	Chief People Officer	Direct	Sale	10,031	112.60	$1,129,490.60	20,990	4
2025-12-17	Tariq, Musa	Director	-	Direct	Sale	116	101.46	$11,769.36	7,993	4
2025-12-15	Eltoukhy, Helmy	Director,Officer	Co-Chief Executive Officer	Direct	Sale	90,565	103.91	$9,410,609.15	2,047,143	4
2025-12-15	Chudova, Darya	Officer	Chief Technology Officer	Direct	Sale	5,451	104.04	$567,122.04	7,012	4
2025-12-08	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Indirect	Sale	100,000	105.18	$10,518,000.00	168,223	4
2025-12-08	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	2,000	104.60	$209,200.00	22,365	4
2025-12-08	Hidalgo, Medina Manuel	Director	-	Direct	Sale	1,250	105.00	$131,250.00	797	4
2025-12-08	Chudova, Darya	Officer	Chief Technology Officer	Direct	Sale	9,271	106.00	$982,726.00	12,463	4
2025-12-05	Freeman, Chris	Officer	Chief Commercial Officer	Direct	Sale	31,452	103.76	$3,263,459.52	25,987	4
2025-12-05	Clark, Ian T	Director	-	Indirect	Sale	28,611	107.33	$3,070,818.63	9,851	4
2025-12-05	Bell, Michael Brian	Officer	Chief Financial Officer	Direct	Sale	80,362	104.00	$8,357,648.00	28,052	4
2025-12-01	Monroe, Terilyn J.	Officer	Chief People Officer	Direct	Sale	55,167	106.40	$5,869,768.80	20,920	4
2025-11-19	Tariq, Musa	Director	-	Direct	Sale	116	96.25	$11,165.00	7,859	4
2025-11-07	Hidalgo, Medina Manuel	Director	-	Direct	Sale	1,500	95.20	$142,800.00	815	4
2025-11-07	Saia, John G.	Officer	Chief Legal Officer	Direct	Sale	8,996	96.25	$865,865.00	43,172	4
2025-10-17	Potter, Myrtle S	Director	-	Direct	Sale	26	66.95	$1,740.70	18,324	4
2025-10-17	Tariq, Musa	Director	-	Direct	Sale	116	66.95	$7,766.20	7,725	4
2025-09-17	Potter, Myrtle S	Director	-	Direct	Sale	26	55.63	$1,446.38	18,281	4
2025-09-17	Tariq, Musa	Director	-	Direct	Sale	116	55.63	$6,453.08	7,591	4
2025-09-12	Hidalgo, Medina Manuel	Director	-	Direct	Sale	2,165	54.16	$117,256.40	851	4
2025-09-09	Eltoukhy, Helmy	Director,Officer	Co-Chief Executive Officer	Direct	Sale	300,000	59.68	$17,904,000.00	2,123,499	4
2025-09-02	Joyce, Meghan V.	Director	-	Direct	Sale	100	65.84	$6,584.00	11,183	4
2025-08-21	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	2,000	61.76	$123,520.00	18,500	4
2025-08-19	Potter, Myrtle S	Director	-	Direct	Sale	26	59.02	$1,534.52	18,239	4
2025-08-19	Tariq, Musa	Director	-	Direct	Sale	116	59.02	$6,846.32	7,458	4
2025-07-17	Tariq, Musa	Director	-	Direct	Sale	116	48.20	$5,591.20	7,324	4
2025-07-17	Potter, Myrtle S	Director	-	Direct	Sale	26	48.20	$1,253.20	18,196	4
2025-07-01	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Direct	Sale	100,000	51.04	$5,104,000.00	1,971,830	4
2025-06-18	Potter, Myrtle S	Director	-	Direct	Sale	26	49.47	$1,286.22	18,154	4
2025-06-18	Tariq, Musa	Director	-	Direct	Sale	3,213	49.47	$158,947.11	7,190	4
2025-06-17	Clark, Ian T	Director	-	Indirect	Sale	6,672	48.38	$322,791.36	9,851	4
2025-06-16	Potter, Myrtle S	Director	-	Direct	Sale	2,626	49.70	$130,512.20	18,180	4
2025-06-13	Joyce, Meghan V.	Director	-	Direct	Sale	3,337	47.22	$157,573.14	11,150	4
2025-06-09	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Direct	Sale	77,853	50.09	$3,899,656.77	2,069,456	4
2025-06-03	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	4,000	46.39	$185,560.00	18,765	4
2025-06-02	Joyce, Meghan V.	Director	-	Direct	Sale	100	41.66	$4,166.00	7,746	4
2025-05-19	Tariq, Musa	Director	-	Direct	Sale	116	40.04	$4,644.64	3,479	4
2025-05-02	Talasaz, Amirali	Director,Officer	Co-Chief Executive Officer	Direct	Sale	13,932	50.47	$703,148.04	2,188,740	4
2025-04-17	Tariq, Musa	Director	-	Direct	Sale	116	44.79	$5,195.64	3,345	4
2025-03-19	Tariq, Musa	Director	-	Direct	Sale	116	43.70	$5,069.20	3,211	4
2025-03-17	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	3,500	43.16	$151,060.00	19,720	4
2025-03-03	Joyce, Meghan V.	Director	-	Direct	Sale	100	42.71	$4,271.00	7,647	4
2025-02-20	Tariq, Musa	Director	-	Direct	Sale	116	48.33	$5,606.28	3,078	4
2025-01-17	Tariq, Musa	Director	-	Direct	Sale	116	37.58	$4,359.28	2,944	4
2024-12-18	Tariq, Musa	Director	-	Direct	Sale	116	34.85	$4,042.60	2,810	4
2024-12-13	Tariq, Musa	Director	-	Direct	Sale	2,320	35.00	$81,200.00	2,676	4
2024-12-02	Joyce, Meghan V.	Director	-	Direct	Sale	100	35.90	$3,590.00	7,548	4
2024-11-18	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	7,000	29.25	$204,750.00	17,744	4
2024-11-13	Joyce, Meghan V.	Director	-	Direct	Sale	2,896	29.90	$86,590.40	7,648	4
2024-11-12	Clark, Ian T	Director	-	Direct	Sale	8,318	29.48	$245,214.64	8,435	4
2024-06-04	Joyce, Meghan V.	Director	-	Direct	Sale	100	27.87	$2,787.00	4,621	4
2024-03-18	Kalia, Kumud	Officer	Chief Information Officer	Direct	Purchase	2,187	17.82	$38,972.34	12,722	4
2024-03-04	Joyce, Meghan V.	Director	-	Direct	Sale	100	19.05	$1,905.00	4,521	4
2023-12-04	Joyce, Meghan V.	Director	-	Direct	Sale	100	26.34	$2,634.00	4,422	4
2023-12-01	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	5,800	26.37	$152,946.00	5,926	4
2023-09-12	Kalia, Kumud	Officer	Chief Information Officer	Direct	Sale	2,125	32.59	$69,253.75	7,813	4
2023-09-05	Joyce, Meghan V.	Director	-	Direct	Sale	100	35.01	$3,501.00	4,323	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

94.91%

Inst. Shares: 124,591,853

Shares Outstanding: 131,273,000

2025-12-31

97.89%

Inst. Shares: 122,727,439

Shares Outstanding: 125,374,000

2025-09-30

93.05%

Inst. Shares: 116,127,200

Shares Outstanding: 124,807,000

2025-06-30

97.17%

Inst. Shares: 120,606,544

Shares Outstanding: 124,114,000

2025-03-31

93.61%

Inst. Shares: 115,957,235

Shares Outstanding: 123,871,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	124,591,853	131,273,000	94.91%
2025-12-31	122,727,439	125,374,000	97.89%
2025-09-30	116,127,200	124,807,000	93.05%
2025-06-30	120,606,544	124,114,000	97.17%
2025-03-31	115,957,235	123,871,000	93.61%
2024-12-31	118,475,095	122,745,000	96.52%
2024-09-30	119,921,749	123,051,000	97.46%
2024-06-30	110,672,485	122,447,000	90.38%
2024-03-31	105,708,044	121,712,000	86.85%
2023-12-31	105,096,913	111,988,000	93.85%
2023-09-30	100,276,485	117,736,000	85.17%
2023-06-30	101,282,317	108,808,000	93.08%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Guardant Health, Inc. (GH) — SEC Financial Statements & Analysis

Guardant Health, Inc. (GH) is a services-medical laboratories company, incorporated in DE. Guardant Health, Inc. trades on GH: Nasdaq as: GH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Guardant Health, Inc. reported a 39.56% year-over-year revenue growth, a Gross Profit Margin of 64.90% (TTM), a Debt-to-Equity ratio of -11.58x, a Price-to-Sales (P/S) ratio of 11.23x (TTM), a Price-to-Book (P/B) ratio of -66.97 (TTM), at a market cap of $12.13B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 39.56%
Gross Profit Margin TTM: 64.90%
Debt To Equity: -11.58x
P/S TTM: 11.23x
P/B TTM: -66.97
Market Cap: $12.13B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Guardant Health, Inc. in?

Guardant Health, Inc. (GH) operates in the Services-Medical Laboratories industry.

What is GH's market cap?

Guardant Health, Inc. (GH) has a market capitalization of $12.13B as of 2026-03-31.

What exchange does GH trade on?

Guardant Health, Inc. (GH) trades on the GH: Nasdaq.

Where is Guardant Health, Inc. incorporated?

Guardant Health, Inc. is incorporated in DE.

Guardant Health, Inc. (GH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.